These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36857023)

  • 1. Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status.
    Liao CY; Lee CC; Yang HC; Chen CJ; Chung WY; Wu HM; Guo WY; Liu RS; Lu CF
    Phys Eng Sci Med; 2023 Jun; 46(2):585-596. PubMed ID: 36857023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer.
    Lu CF; Liao CY; Chao HS; Chiu HY; Wang TW; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
    Cancer Imaging; 2023 Jan; 23(1):9. PubMed ID: 36670497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
    Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
    Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
    Huang CY; Lee CC; Yang HC; Lin CJ; Wu HM; Chung WY; Shiau CY; Guo WY; Pan DH; Peng SJ
    J Neurooncol; 2020 Feb; 146(3):439-449. PubMed ID: 32020474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
    Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
    Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases.
    Liao CY; Lee CC; Yang HC; Chen CJ; Chung WY; Wu HM; Guo WY; Liu RS; Lu CF
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized prediction of immunotherapy response in lung cancer patients using advanced radiomics and deep learning.
    Liao CY; Chen YM; Wu YT; Chao HS; Chiu HY; Wang TW; Chen JR; Shiao TH; Lu CF
    Cancer Imaging; 2024 Sep; 24(1):129. PubMed ID: 39350284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer.
    Na YC; Jung HH; Kim HR; Cho BC; Chang JW; Park YG; Chang WS
    J Neurooncol; 2017 Apr; 132(2):333-340. PubMed ID: 28074321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors.
    Wang TW; Chao HS; Chiu HY; Lu CF; Liao CY; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
    Transl Oncol; 2024 Jan; 39():101826. PubMed ID: 37984256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
    Haim O; Abramov S; Shofty B; Fanizzi C; DiMeco F; Avisdris N; Ram Z; Artzi M; Grossman R
    J Neurooncol; 2022 Mar; 157(1):63-69. PubMed ID: 35119589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
    Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
    Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
    Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
    Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
    Liao HR; Chiang CL; Shen CI; Chen CJ; Yang HC; Wu HM; Luo YH; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Pan DH; Lee CC
    J Neurooncol; 2022 Sep; 159(3):675-684. PubMed ID: 35976545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
    Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ
    J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients.
    Yomo S; Oda K
    Lung Cancer; 2018 May; 119():120-126. PubMed ID: 29656746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.
    Du P; Liu X; Xiang R; Lv K; Chen H; Liu W; Cao A; Chen L; Wang X; Yu T; Ding J; Li W; Li J; Li Y; Yu Z; Zhu L; Liu J; Geng D
    Eur Radiol; 2023 Dec; 33(12):8925-8935. PubMed ID: 37505244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.